Sophia Genetics (Sophia Genetics) EV-to-Revenue : 3.43 (As of May. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sophia Genetics's enterprise value is $220.32 Mil. Sophia Genetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $64.18 Mil. Therefore, Sophia Genetics's EV-to-Revenue for today is 3.43.

The historical rank and industry rank for Sophia Genetics's EV-to-Revenue or its related term are showing as below:

SOPH' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.74 Med: 2.77 Max: 34.3
Current: 3.43

During the past 6 years, the highest EV-to-Revenue of Sophia Genetics was 34.30. The lowest was -1.74. And the median was 2.77.

SOPH's EV-to-Revenue is ranked worse than
70.39% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 1.89 vs SOPH: 3.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Sophia Genetics's stock price is $4.69. Sophia Genetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.99. Therefore, Sophia Genetics's PS Ratio for today is 4.75.

Sophia Genetics EV-to-Revenue Historical Data

The historical data trend for Sophia Genetics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics EV-to-Revenue Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

16.02

-0.62

3.25

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial													3.47	3.01	0.87	3.25	3.68

Competitive Comparison of Sophia Genetics's EV-to-Revenue

For the Health Information Services subindustry, Sophia Genetics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sophia Genetics's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's EV-to-Revenue falls into.

Sophia Genetics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sophia Genetics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	220.316	/	64.184
	=	3.43

Sophia Genetics's current Enterprise Value is $220.32 Mil.
Sophia Genetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $64.18 Mil.

Sophia Genetics (NAS:SOPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sophia Genetics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	4.69	/	0.988
	=	4.75

Sophia Genetics's share price for today is $4.69.
Sophia Genetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.99.

Sophia Genetics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics (Sophia Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

Rue du Centre 172, Saint-Sulpice, CHE, CH-1025

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.